The Influenza A Virus Replication Cycle: A Comprehensive Review

Toby Carter,Munir Iqbal
DOI: https://doi.org/10.3390/v16020316
2024-02-20
Viruses
Abstract:Influenza A virus (IAV) is the primary causative agent of influenza, colloquially called the flu. Each year, it infects up to a billion people, resulting in hundreds of thousands of human deaths, and causes devastating avian outbreaks with worldwide losses worth billions of dollars. Always present is the possibility that a highly pathogenic novel subtype capable of direct human-to-human transmission will spill over into humans, causing a pandemic as devastating if not more so than the 1918 influenza pandemic. While antiviral drugs for influenza do exist, they target very few aspects of IAV replication and risk becoming obsolete due to antiviral resistance. Antivirals targeting other areas of IAV replication are needed to overcome this resistance and combat the yearly epidemics, which exact a serious toll worldwide. This review aims to summarise the key steps in the IAV replication cycle, along with highlighting areas of research that need more focus.
virology
What problem does this paper attempt to address?
This paper aims to address the key steps in the replication cycle of influenza viruses (especially Influenza A Virus, IAV) and their mechanisms. Specifically, through a comprehensive review of existing research, the paper summarizes the main steps in the entire process of IAV from entering host cells to releasing new virus particles, including virus endocytosis, transcription and replication of the genome in the nucleus, and assembly and release of new virus particles. In addition, the paper also emphasizes the research areas that need more attention, especially in the development of antiviral drugs, pointing out that current antiviral drugs only target a few aspects of the IAV replication process and are at risk of becoming ineffective due to drug resistance. Therefore, the development of new antiviral drugs targeting other replication steps is crucial for overcoming drug resistance and effectively responding to the annual influenza epidemic. In short, the main objective of this review paper is to summarize the key steps in the IAV replication cycle and explore the key directions for future research, with the hope of providing a theoretical basis for new antiviral strategies.